Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study

This publication has 14 references indexed in Scilit:

• Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome–related Kaposi sarcoma
  Cancer, 2003
• AIDS-Related Kaposi’s Sarcoma: Evaluation of Potential New Prognostic Factors and Assessment of the AIDS Clinical Trial Group Staging System in the Haart Era—the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naïve From Antiretrovirals
  Journal of Clinical Oncology, 2003
• Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)
  International Journal of Cancer, 2003
• Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma
  Cancer, 2002
• Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy
  Published by Elsevier ,2002
• Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients
  AIDS, 2000
• Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
  Journal of Clinical Oncology, 1998
• Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
  The Lancet, 1995
• Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
  JNCI Journal of the National Cancer Institute, 1991
• Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
  Journal of Clinical Oncology, 1989